|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/713 | (2006.01) |
| (11) | Number of the document | 3218489 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15797762.0 |
| Date of filing the European patent application | 2015-11-10 | |
| (97) | Date of publication of the European application | 2017-09-20 |
| (45) | Date of publication and mention of the grant of the patent | 2019-10-09 |
| (46) | Date of publication of the claims translation | 2019-12-27 |
| (86) | Number | PCT/US2015/059916 |
| Date | 2015-11-10 |
| (87) | Number | WO 2016/077321 |
| Date | 2016-05-19 |
| (30) | Number | Date | Country code |
| 201462077672 P | 2014-11-10 | US | |
| 201462077799 P | 2014-11-10 | US | |
| 201562137464 P | 2015-03-24 | US |
| (72) |
HINKLE, Gregory, US
SEPP-LORENZINO, Laura, US
JADHAV, Vasant, US
MAIER, Martin, US
MILSTEIN, Stuart, US
MANOHARAN, Muthiah, US
RAJEEV, Kallanthottathil, G., US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, 3rd Floor, Cambridge, MA 02142,
US
|
| (74) |
Nelia JANIUŠINA,
UAB „FONDIA LIETUVA“ Gedimino pr. 20, LT-01103 Vilnius,
LT
|
| (54) | Hepatito B viruso (HBV) iRNR kompozicijos ir jų naudojimo būdai |
| HEPATITIS B VIRUS (HBV) iRNA COMPOSITIONS AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2025-10-20 | 11 | 289.00 EUR |
| 2026-11-10 |